TI
FBRX

Trexquant Investment’s Forte Biosciences FBRX Stock Holding History

Trexquant Investment’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$535K Sell
25,168
-48,483
-66% -$1.15M ﹤0.01% 1622
2026
Q1 		$1.91M Buy
73,651
+60,735
+470% +$1.75M 0.01% 1014
2025
Q4 		$352K Buy
+12,916
New +$226K ﹤0.01% 1418
2021
Q3 		– Sell
-303
Closed -$255K – 1245
2021
Q2 		$255K Buy
+303
New +$273K 0.02% 793
2019
Q1 		– Sell
-137
Closed -$421K – 1085
2018
Q4 		$421K Buy
+137
New +$590K 0.03% 670

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Trexquant Investment's FBRX Position: Q2 2026 in Review

Trexquant Investment reduced its Forte Biosciences (FBRX) stake by 66% in Q2 2026, selling an estimated $1.15M and leaving 25,168 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Trexquant Investment first reported a position in FBRX in Q4 2018 and has held it in 5 quarters since. The position peaked at $1.91M in Q1 2026. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Trexquant Investment held 25,168 shares of Forte Biosciences worth $535K as of Q2 2026.
  • Trexquant Investment sold 48,483 Forte Biosciences shares in Q2 2026, an estimated $1.15M.
  • Forte Biosciences made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1622 holding.
  • Trexquant Investment first reported a position in Forte Biosciences in Q4 2018 and has held it in 5 quarters since.
  • Trexquant Investment's Forte Biosciences position peaked at $1.91M in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.